Targeting Histone Deacetylase in Cardiac Diseases

Overview

Journal Front Physiol

Date 2024 Jul 10

PMID 38983721

Authors

Jiao Lu

Sichong Qian

Zheng Sun

Affiliations

Soon will be listed here.

Abstract

Histone deacetylases (HDAC) catalyze the removal of acetylation modifications on histones and non-histone proteins, which regulates gene expression and other cellular processes. HDAC inhibitors (HDACi), approved anti-cancer agents, emerge as a potential new therapy for heart diseases. Cardioprotective effects of HDACi are observed in many preclinical animal models of heart diseases. Genetic mouse models have been developed to understand the role of each HDAC in cardiac functions. Some of the findings are controversial. Here, we provide an overview of how HDACi and HDAC impact cardiac functions under physiological or pathological conditions. We focus on studies of zinc-dependent classical HDACs, emphasizing disease conditions involving cardiac hypertrophy, myocardial infarction (MI), ischemic reperfusion (I/R) injury, and heart failure. In particular, we review how non-biased omics studies can help our understanding of the mechanisms underlying the cardiac effects of HDACi and HDAC.

Citing Articles

Emerging Insights into Sall4's Role in Cardiac Regenerative Medicine.

Yang J Cells. 2025; 14(3).

PMID: 39936946 PMC: 11817359. DOI: 10.3390/cells14030154.

Enzyme-independent functions of HDAC3 in the adult heart.

Qian S, Zhang C, Li W, Song S, Lin G, Cheng Z bioRxiv. 2025; .

PMID: 39803453 PMC: 11722435. DOI: 10.1101/2024.12.29.630635.

Histone Deacetylase (HDAC) Inhibitors as a Novel Therapeutic Option Against Fibrotic and Inflammatory Diseases.

Theodoropoulou M, Mantzourani C, Kokotos G Biomolecules. 2025; 14(12.

PMID: 39766311 PMC: 11674560. DOI: 10.3390/biom14121605.

References

Zhang L, Du J, Yano N, Wang H, Zhao Y, Dubielecka P . Sodium Butyrate Protects -Against High Fat Diet-Induced Cardiac Dysfunction and Metabolic Disorders in Type II Diabetic Mice. J Cell Biochem. 2017; 118(8):2395-2408. PMC: 5462877. DOI: 10.1002/jcb.25902. View

Zhang L, Qin X, Zhao Y, Fast L, Zhuang S, Liu P . Inhibition of histone deacetylases preserves myocardial performance and prevents cardiac remodeling through stimulation of endogenous angiomyogenesis. J Pharmacol Exp Ther. 2012; 341(1):285-93. PMC: 3310703. DOI: 10.1124/jpet.111.189910. View

Yan M, Chen C, Gong W, Yin Z, Zhou L, Chaugai S . miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8. Cardiovasc Res. 2014; 105(3):340-52. DOI: 10.1093/cvr/cvu254. View

Lecce L, Xu Y, VGangula B, Chandel N, Pothula V, Caudrillier A . Histone deacetylase 9 promotes endothelial-mesenchymal transition and an unfavorable atherosclerotic plaque phenotype. J Clin Invest. 2021; 131(15). PMC: 8321575. DOI: 10.1172/JCI131178. View

Subramanian S, Bates S, Wright J, Espinoza-Delgado I, Piekarz R . Clinical Toxicities of Histone Deacetylase Inhibitors. Pharmaceuticals (Basel). 2016; 3(9):2751-2767. PMC: 4034096. DOI: 10.3390/ph3092751. View

Zhang L, Du J, Zhao Y, Wang J, Zhang S, Dubielecka P . Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium. J Appl Physiol (1985). 2018; 125(6):1968-1978. PMC: 6737459. DOI: 10.1152/japplphysiol.00006.2018. View

Maes K, Menu E, Van Valckenborgh E, Van Riet I, Vanderkerken K, de Bruyne E . Epigenetic modulating agents as a new therapeutic approach in multiple myeloma. Cancers (Basel). 2013; 5(2):430-61. PMC: 3730337. DOI: 10.3390/cancers5020430. View

Chang S, McKinsey T, Zhang C, Richardson J, Hill J, Olson E . Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development. Mol Cell Biol. 2004; 24(19):8467-76. PMC: 516756. DOI: 10.1128/MCB.24.19.8467-8476.2004. View

Cai C, Liang X, Shi Y, Chu P, Pfaff S, Chen J . Isl1 identifies a cardiac progenitor population that proliferates prior to differentiation and contributes a majority of cells to the heart. Dev Cell. 2003; 5(6):877-89. PMC: 5578462. DOI: 10.1016/s1534-5807(03)00363-0. View

10.

Liu F, Levin M, Petrenko N, Lu M, Wang T, Yuan L . Histone-deacetylase inhibition reverses atrial arrhythmia inducibility and fibrosis in cardiac hypertrophy independent of angiotensin. J Mol Cell Cardiol. 2008; 45(6):715-23. PMC: 2630487. DOI: 10.1016/j.yjmcc.2008.08.015. View

11.

Wang D, Fang C, Zong N, Liem D, Cadeiras M, Scruggs S . Regulation of acetylation restores proteolytic function of diseased myocardium in mouse and human. Mol Cell Proteomics. 2013; 12(12):3793-802. PMC: 3861724. DOI: 10.1074/mcp.M113.028332. View

12.

Lee E, Lee H, Kim M, Do G, Cho H, Kim G . Upregulation of C/EBPβ and TSC2 by an HDAC inhibitor CG200745 protects heart from DOCA-induced hypertrophy. Clin Exp Pharmacol Physiol. 2018; 46(3):226-236. DOI: 10.1111/1440-1681.13022. View

13.

Karoor V, Strassheim D, Sullivan T, Verin A, Umapathy N, Dempsey E . The Short-Chain Fatty Acid Butyrate Attenuates Pulmonary Vascular Remodeling and Inflammation in Hypoxia-Induced Pulmonary Hypertension. Int J Mol Sci. 2021; 22(18). PMC: 8467617. DOI: 10.3390/ijms22189916. View

14.

Jeong M, Lin Y, Wennersten S, Demos-Davies K, Cavasin M, Mahaffey J . Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism. Sci Transl Med. 2018; 10(427). PMC: 5908215. DOI: 10.1126/scitranslmed.aao0144. View

15.

Vega R, Matsuda K, Oh J, Barbosa A, Yang X, Meadows E . Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis. Cell. 2004; 119(4):555-66. DOI: 10.1016/j.cell.2004.10.024. View

16.

Yang J, He J, Ismail M, Tweeten S, Zeng F, Gao L . HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia/reperfusion injury. J Mol Cell Cardiol. 2019; 130:36-48. PMC: 6502701. DOI: 10.1016/j.yjmcc.2019.03.008. View

17.

Na J, Jin H, Wang X, Huang K, Sun S, Li Q . The crosstalk of HDAC3, microRNA-18a and ADRB3 in the progression of heart failure. Cell Biosci. 2021; 11(1):31. PMC: 7866688. DOI: 10.1186/s13578-020-00523-y. View

18.

Lehmann L, Jebessa Z, Kreusser M, Horsch A, He T, Kronlage M . A proteolytic fragment of histone deacetylase 4 protects the heart from failure by regulating the hexosamine biosynthetic pathway. Nat Med. 2017; 24(1):62-72. DOI: 10.1038/nm.4452. View

19.

Kitagawa Y, Tamura Y, Shimizu J, Nakajima-Takenaka C, Taniguchi S, Uesato S . Effects of a novel histone deacetylase inhibitor, N-(2-aminophenyl) benzamide, on a reversible hypertrophy induced by isoproterenol in in situ rat hearts. J Pharmacol Sci. 2007; 104(2):167-75. DOI: 10.1254/jphs.fp0070091. View

20.

Qiu Z, Ming H, Lei S, Zhou B, Zhao B, Yu Y . Roles of HDAC3-orchestrated circadian clock gene oscillations in diabetic rats following myocardial ischaemia/reperfusion injury. Cell Death Dis. 2021; 12(1):43. PMC: 7791027. DOI: 10.1038/s41419-020-03295-y. View